Many factors are inciting the global in vitro diagnostics (IVD) market growth; one of the primary reasons is the upswing in the number of chronic and infectious diseases cases. Besides, an upturn in the aged population is also propelling rapid testing at the bedside considerably.
In this landscape, the technologies most heavily influenced by these trends are point-of-care (POC), molecular diagnostics, and liquid biopsy used in conjunction with in vitro diagnostics. POC technology, in particular, is becoming increasingly crucial in response to the expanding need to identify both chronic and infectious diseases rapidly. The incorporation of smart devices into POC diagnostics is significantly increasing the safety, accuracy, and user-friendliness of this technology. Biosensors are another example of newer POC testing technology that is gaining increased sensitivity as research advances. A typical example of biosensors used in POC diagnostics is the commercially-available blood glucose monitor.
Amid such trends making a wave in the in vitro diagnostic sector, it is becoming imperative for healthcare organisations to equip themselves with the latest and emerging technologies in the market. In order to assist such companies to shore up their capabilities, we have compiled this issue of MedTech Outlook. In this edition, we have listed the top 10 in vitro diagnostic solution providers and top 10 emerging in vitro diagnostic solution providers. Equipped with innovative technological capabilities, these enlisted providers are transforming the IVD landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject matter experts, CIOs, and CXOs on the latest industry trends, best practices, and recent innovations, and highlights their expertise. We hope this issue of MedTech Outlook helps you build the partnership you and your organisation need to foster an healthcare ecosystem driven by robust and efficient technology.
We present to you MedTech Outlook’s “Top 10 Emerging In Vitro Diagnostic Solution Providers – 2021.”